Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.18 - $0.86 $52,459 - $250,641
-291,444 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$0.6 - $1.06 $105,000 - $185,500
175,000 Added 150.29%
291,444 $816,000
Q3 2021

Nov 15, 2021

SELL
$1.33 - $1.77 $304,511 - $405,252
-228,956 Reduced 66.29%
116,444 $155,000
Q2 2021

Aug 16, 2021

BUY
$1.41 - $1.94 $487,014 - $670,076
345,400 New
345,400 $497,000

About ATHERSYS, INC


  • Ticker ATHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 305,110,016
  • Market Cap $3.05M
  • Description
  • Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...
More about ATHX
Track This Portfolio

Track Sabby Management, LLC Portfolio

Follow Sabby Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sabby Management, LLC with notifications on news.